Michael Kinch

Michael S. Kinch

Michael S. Kinch, Ph.D. is Associate Vice Chancellor at Washington University in St Louis, where he helps lead entrepreneurship activities as well as research on innovation in biopharmaceutical research and development. Michael founded and leads the Centers for Research Innovation in Biotechnology (CRIB) and Drug Development (CDD).
Dr. Kinch’s scientific background includes the development of new medicines for cancer, immunological and infectious diseases. His current work is primarily focused upon understanding the blend of science, medicine, business and law needed to support the development of new medicines. Prior to joining Washington University in July 2014, he led drug discovery at Yale University as Managing Director of the Yale Center for Molecular Discovery.
Before joining Yale in 2010, Dr. Kinch had served as Vice President of Research & Development and Chief Scientific Officer at Functional Genetics, Inc. in Gaithersburg, MD, where his research included investigation of Ebola virus, Dengue fever virus, pandemic influenza and other emerging infectious diseases. Preceding that, Dr. Kinch founded and led the Departments of Cancer Biology and In Vivo Biology at MedImmune, Inc.
Prior to MedImmune, Dr. Kinch served as a tenured Associate Professor of Cellular Pharmacology at Purdue University in West Lafayette, IN. He has published more than 100 manuscripts, been granted 15 US patents and published more than 100 pending patents.
His first book, A Prescription for Change (UNC Press, 2016), outlines a history of the biotechnology and pharmaceutical industries. Michael’s second book, Between Hope and Fear: A History of Vaccines (Pegasus Books, 2018) details a history of new cancer therapies based on immune oncology. His third book, The End of the Beginning, provides the history of new cancer therapies with the potential promise to eradicate this disease. Dr. Kinch was a postdoctoral fellow at the University of North Carolina at Chapel Hill, obtained a Ph.D. in Immunology from Duke University and a B.S. in Molecular Genetics from The Ohio State University.

BOOKS

A Prescription for Change

Between Hope and Fear

End of the Beginning

CONNECT

Authors Unbound

Pegasus Books

REPRESENTATION

Literary Agent: Don Fehr | Trident Media

Publicist:  Jessica Case | Pegasus Books

Speaking Engagements | Dani Macbain | Authors Unbound

PRESS COVERAGE of CRIB ACTIVITIES